Aug 10 (Reuters) – New data on the heart benefit of an obesity drug from Novo Nordisk (NOVOb.CO) increases the chances of a pay-off for it and Eli Lilly, which have spent a record amount on U.S. lobb… [read more]
Obesity drug data could boost companies’ case for US coverage analysts say – Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/4XTTY63IJVI3JIDD3KWEP7BDFI.jpg "Obesity drug data could boost companies’ case for US coverage analysts say – Reuters")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/K544QF23CFPCNCP26X4TBOZTSU.jpg "Toshiba says $14 bln takeover bid by JIP succeeds set to go private – Reuters")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UY2SWAEOP5OVJEQ4YLFSQBQ3VY.jpg "OpenAI unveils Dall-E 3 latest version of its text-to-image tool – Reuters.com")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PCA4DEUVPRO4VNY6F7AEBY6CYM.jpg "Stocks retreat US yields advance dollar strengthens on hawkish Fed – Reuters.com")